Former Technical Advisory Group (TAG) members
MVI makes routine use of technical advisory groups (TAGs), which comprise external experts in malaria, vaccine development, immunology, industry, and clinical trial design and evaluation. TAGs may be convened at key points throughout the life cycle of a vaccine project, including prior to project initiation, in response to new or important data, and at the request of MVI’s internal Portfolio Management Committee.
President and CEO, Biologics Consulting Group, Inc.
Associate Professor, Radboud University Nijmegen Medical Centre
Chief, Flow Cytometry Center, Walter Reed Army Institute of Research (WRAIR)
Chief, Malaria Infection Biology and Immunity Unit, National Institute of Allergy and Infectious Diseases (NIAID)
Senior Director, Discovery Research, Takeda Vaccine Business Unit
Associate Professor, Johns Hopkins Bloomberg School of Public Health
Director, Clinical and Regulatory Affairs, Vaccine Development Global Program, PATH
Chief, Viral Pathogenesis Laboratory, National Institute of Allergy and Infectious Diseases (NIAID)
Senior Vice President, Vaccine Clinical Research and Development, Pfizer
Chief, Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research
Chief Scientific and Chief Operating Officer, BioProtection Systems/NewLink Genetics Corp.
Technical Officer, Department of Immunization, Vaccines, and Biologicals, World Health Organization
Heidelberg University Hospital, Centre for Infectious Diseases, Parasitology Unit
Chief Scientific Officer, Vaccine and Gene Therapy Institute of Florida
Professor Adjunct, The Scripps Institute
Deputy Director, Clinical, Henry Jackson Foundation, US Military HIV Research
Director for Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention
Professor, Dept. of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University